State Of Alaska, Department Of Revenue Abb Vie Inc. Transaction History

State Of Alaska, Department Of Revenue

$8.78 Billion
Q1 2024

A detailed history of State Of Alaska, Department Of Revenue transactions in Abb Vie Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 295,759 shares of ABBV stock, worth $50.7 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

295,759

Previous 305,994 3.34%

Holding current value

$50.7 Million

Previous $47.4 Million 13.58%

% of portfolio

0.61%

Previous 0.56%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $1.64 Million - $1.86 Million	-10,235 Reduced 3.34%	295,759 $53.9 Million
Q4 2023 Jan 19, 2024	SELL	$137.6 - $154.97 $1.87 Million - $2.1 Million	-13,555 Reduced 4.24%	305,994 $47.4 Million
Q3 2023 Oct 16, 2023	SELL	$133.59 - $154.65 $1.15 Million - $1.33 Million	-8,590 Reduced 2.62%	319,549 $47.6 Million
Q2 2023 Jul 24, 2023	BUY	$132.51 - $164.9 $1.51 Million - $1.87 Million	11,369 Added 3.59%	328,139 $44.2 Million
Q1 2023 Apr 17, 2023	SELL	$144.61 - $166.54 $533,755 - $614,699	-3,691 Reduced 1.15%	316,770 $50.5 Million

Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $195,985 - $235,037	1,417 Added 0.44%	320,461 $51.8 Million
Q3 2022 Oct 20, 2022	SELL	$134.21 - $153.93 $1.13 Million - $1.3 Million	-8,438 Reduced 2.58%	319,044 $42.8 Million
Q2 2022 Jul 08, 2022	BUY	$137.62 - $174.96 $2.84 Million - $3.6 Million	20,601 Added 6.71%	327,482 $50.2 Million
Q1 2022 Apr 14, 2022	SELL	$131.98 - $163.75 $1.02 Million - $1.27 Million	-7,731 Reduced 2.46%	306,881 $49.7 Million
Q4 2021 Jan 12, 2022	SELL	$107.43 - $135.93 $1.72 Million - $2.18 Million	-16,018 Reduced 4.84%	314,612 $42.6 Million
Q3 2021 Oct 07, 2021	BUY	$106.4 - $120.78 $2.75 Million - $3.12 Million	25,864 Added 8.49%	330,630 $35.7 Million
Q2 2021 Jul 12, 2021	BUY	$105.21 - $117.21 $459,978 - $512,442	4,372 Added 1.46%	304,766 $34.3 Million
Q1 2021 Apr 09, 2021	BUY	$102.3 - $112.62 $240,814 - $265,107	2,354 Added 0.79%	300,394 $32.5 Million
Q4 2020 Jan 08, 2021	SELL	$80.49 - $108.67 $816,973 - $1.1 Million	-10,150 Reduced 3.29%	298,040 $31.9 Million
Q3 2020 Oct 05, 2020	SELL	$85.91 - $100.83 $3.39 Million - $3.98 Million	-39,517 Reduced 11.37%	308,190 $27 Million
Q2 2020 Jul 06, 2020	BUY	$73.37 - $98.18 $6.66 Million - $8.91 Million	90,797 Added 35.34%	347,707 $34.1 Million
Q1 2020 Apr 06, 2020	BUY	$64.5 - $97.79 $894,873 - $1.36 Million	13,874 Added 5.71%	256,910 $19.6 Million
Q4 2019 Jan 07, 2020	SELL	$72.13 - $90.25 $1.44 Million - $1.8 Million	-19,968 Reduced 7.59%	243,036 $21.5 Million
Q3 2019 Oct 02, 2019	BUY	$62.98 - $75.72 $3.82 Million - $4.59 Million	60,664 Added 29.98%	263,004 $19.9 Million
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $64,057 - $81,880	975 Added 0.48%	202,340 $14.7 Million
Q1 2019 Apr 09, 2019	SELL	$77.14 - $90.79 $2.04 Million - $2.4 Million	-26,439 Reduced 11.61%	201,365 $16.2 Million
Q4 2018 Jan 10, 2019	BUY	$77.85 - $96.01 $151,184 - $186,451	1,942 Added 0.86%	227,804 $21 Million
Q3 2018 Oct 09, 2018	SELL	$88.91 - $98.84 $670,114 - $744,957	-7,537 Reduced 3.23%	225,862 $21.4 Million
Q2 2018 Jul 10, 2018	BUY	$89.78 - $106.23 $3.98 Million - $4.7 Million	44,276 Added 23.41%	233,399 $21.6 Million
Q1 2018 Apr 19, 2018	BUY	$92.01 - $123.21 $1.25 Million - $1.67 Million	13,560 Added 7.72%	189,123 $17.9 Million
Q4 2017 Jan 19, 2018	BUY	$89.56 - $98.21 $13.4 Million - $14.7 Million	149,538 Added 574.59%	175,563 $17 Million
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $1.82 Million - $2.32 Million	26,025	26,025 $2.31 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account

State Of Alaska, Department Of Revenue Abb Vie Inc. Transaction History